Piramal Pharma Limited
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.70 INR per share, beating the −0.24 INR estimate by −185.71%. Revenue for the same period reached 21.40 B INR, despite the estimate of 22.07 B INR. For the next quarter, analysts expect 0.84 INR in earnings per share and 27.31 B INR in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise